This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

HEXO Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for HEXO.

Key information

83.6%

Earnings growth rate

85.0%

EPS growth rate

Pharmaceuticals earnings growth21.4%
Revenue growth rate-0.7%
Future return on equityn/a
Analyst coverage

Low

Last updated22 Jun 2023

Recent future growth updates

Recent updates

Hexo to produce Mike Tyson's cannabis brand's products in Canada

Aug 30

Canopy Growth, Tilray other Canadian cannabis names up amid WallStreetBets chatter

Aug 17

HEXO receives additional 180 calendar day grace period for regaining compliance

Jul 28

HEXO wins shareholder approval for note transaction with Tilray

Jul 05

HEXO: Undervalued, But With Certain Dilution Risks

Apr 28

HEXO Q1 Earnings: Not A Great Path Forward

Dec 14

Earnings and Revenue Growth Forecasts

NasdaqCM:HEXO - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
7/31/2025121-1948402
7/31/2024108-2435232
7/31/2023103-198-4162
4/30/2023124-273-48-39N/A
1/31/2023148-301-63-48N/A
10/31/2022177-1,013-101-89N/A
7/31/2022191-1,074-151-117N/A
4/30/2022187-1,042-181-127N/A
1/31/2022164-918-169-121N/A
10/31/2021144-228-148-93N/A
7/31/2021124-115-75-43N/A
4/30/2021112-214-41-18N/A
1/31/2021112-213-66-23N/A
10/31/202096-491-133-66N/A
7/31/202081-546-204-95N/A
4/30/202069-423-307-174N/A
1/31/202060-411-324-175N/A
10/31/201956-117-299-138N/A
7/31/201948-70-266-125N/A
4/30/201934-35-182-55N/A
1/31/201922-30-155-51N/A
10/31/20189-34-110-42N/A
7/31/20185-23-70-22N/A
4/30/20184-12-39-13N/A
1/31/20184-22-22-10N/A
10/31/20174-14-14-6N/A
7/31/20174-12-9-5N/A
4/30/20174-15-8-4N/A
1/31/20174-3N/A-4N/A
10/31/20163-3N/A-3N/A
7/31/20162-3N/A-3N/A
7/31/20150-3N/A-2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: HEXO is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: HEXO is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: HEXO is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: HEXO's revenue is expected to decline over the next 3 years (-0.7% per year).

High Growth Revenue: HEXO's revenue is forecast to decline over the next 3 years (-0.7% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if HEXO's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.